Month: March 2018

Prexton News

Prexton Acquired by Lundbeck for up to €905m

Oss, The Netherlands & Dublin, Ireland, 16 March 2018 – H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under the terms of the agreement, Lundbeck will pay EUR 100 million upfront plus EUR 805 million in development …

Prexton Acquired by Lundbeck for up to €905m Read More »

Pq Bypass

Doctors Perform ‘Bypass’ Without Surgery

Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week.  Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story was carried on Little Rock’s news source, ArkansasMatters. You can watch a video of the story here and read the full ArkansasMatters story below. Doctors …

Doctors Perform ‘Bypass’ Without Surgery Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top